MEDIA, Pa., Oct. 10 /PRNewswire-FirstCall/ -- Synova Healthcare Group, Inc. (OTC Bulletin Board: SNVH) announced today that it will participate in the National Association of Nurse Practitioners in Women's Health (NPWH) 10th Annual Conference, "Women's Health Care in the New Millennium." The NPWH is the leading association for nurse practitioners providing care to women. The conference will take place October 10 - 13, in Philadelphia, PA. The conference is expected to draw nurse practitioners, nurse midwives and physician assistants from throughout the United States. Synova will be sharing important information about the Today(R) Sponge, a hormone free over the counter female contraceptive and Fem-V(R), a test kit for the symptoms of vaginal infections. Synova is excited to have this opportunity to interact with this diverse group of female healthcare providers who play such an important role in improving women's healthcare.
This meeting provides Synova the opportunity to highlight its Fem-V(R) test kit to this important target audience. Millions of women buy over-the- counter (OTC) vaginal infection treatments, often without knowing the cause of their vaginal infections. Although some infections can be treated with OTC products successfully, it is estimated that sixty-six percent of the time women misdiagnose their symptoms and incorrectly treat with an OTC product, when they actually needed a prescription product from their health care provider. "Nurse practitioners have shared the challenges they face when trying to treat these women," said Maggie Borger, Synova's Product Director. "Our goal is to work with healthcare professionals and consumers to educate women to 'test before they treat with Fem-V(R).' The Fem-V(R) test kit is the only non-invasive, at home test to assess the symptoms of vaginal infections. It is highly accurate with results that match a physician's diagnosis 91% of the time. The Fem-V(R) test kit helps women tell the difference between a yeast infection and something more serious.
The Fem-V(R) test kit is available in select retailers throughout the country. Stephen King, Chairman and CEO of Synova Healthcare Group, Inc. said, "We are extremely pleased to announce that we are expanding our distribution of the Fem-V(R) test kit through Pathmark. Pathmark represents another important point of retail distribution for the Fem-V(R) test kit and increases access to this product for our customers. We believe the Fem-V(R) test kit can play an important role for the millions of women who suffer from vaginal infections annually." According to Pathmark's web site, Pathmark operates 142 supermarkets in New York and New Jersey and in the Philadelphia area. In addition to Pathmark, the Fem-V(R) test kit is available at RITE AID, Duane Reade, Longs Drug, Bi-Lo, Bartell Drugs, Kerr Drug, Kinney Drugs, The Medicine Shoppe, and on-line at amazon.com and drugstore.com. For more information, please visit http://www.fem-v.com
About the Today(R) Sponge:
The Today(R) Sponge is an effective, hormone-free contraceptive that offers 24-hour protection against pregnancy without the potential side effects and long-term commitment associated with hormonal methods. The Today(R) Sponge prevents pregnancy by combining three separate modes of contraceptive action: a barrier method blocking the entry of sperm into the cervix, continual release of spermicide and absorption of sperm by the soft foam sponge. In clinical trials, the Today(R) Sponge has proven to be 89% to 91% effective in preventing pregnancy over a one-year period in 1,800 sponge users.(1) The Today(R) Sponge has particular appeal for those women going through specific lifestyle changes, such as women in-between pregnancies, those who may be breast feeding or newly single, or for those who simply want to avoid the side effects of birth control pills and other hormonal methods. The Today(R) Sponge is available in Canada and the United States at major retailers including: A&P, amazon.com, CVS, drugstore.com, HEB, Longs Drug, Publix, RITE AID, Target, Walgreens and Wal-Mart. For more information, please visit http://www.TodaySponge.com.
About Synova Healthcare Group, Inc.
Synova Healthcare Group, Inc. is committed to delivering innovative products that provide meaningful improvements in women's healthcare. Through its subsidiaries, it is focused on the development, distribution, marketing and sale of women's healthcare products related to contraception, vaginal health, menopause management, fertility planning, obstetrics and personal care. Its goal is to provide healthcare solutions that address every stage of a woman's life. For more information go to http://www.synovahealthcare.com .
This Press Release may contain certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company has tried, whenever possible, to identify these forward-looking statements using words such as "anticipates", "believes", "estimates", "expects", "plans", "intends", "potential" and similar expressions. These statements reflect the Company's current beliefs and are based upon information currently available to it. Accordingly, such forward-looking statements involve known and unknown risks, uncertainties and other factors which could cause the Company's actual results, performance or achievements to differ materially from those expressed in or implied by such statements. Such risks and uncertainties include our ability to successfully market, distribute and sell our products, the acceptance of our products by consumers, our ability to expand our retail distribution network, our ability to compete against similar or other women's healthcare products and the other risks and uncertainties discussed in the Company's Form 10-KSB for the year ended December 31, 2006, as filed with the Securities and Exchange Commission on February 26, 2007, and the Company's Form 10-QSB for the six months ended June 30, 2007, as filed with the SEC on August 14, 2007, as well as in the Company's other periodic reports and filings with the SEC. There can be no assurance that such factors will not affect the accuracy of such forward- looking statements. The Company undertakes no obligation to update or advise in the event of any change, addition or alteration to the information set forth in this Press Release including such forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy, nor will there be any sale of securities of Synova Healthcare Group, Inc. in any state where such offer, solicitation or sale would be unlawful before registration or qualification under the securities laws of those states.
Reference: 1. McClure DA, Edelman DA. Worldwide method effectiveness of the Today(R) vaginal contraceptive sponge. Adv Contracept. 1985;1:305-311.
|SOURCE Synova Healthcare Group, Inc.|
Copyright©2007 PR Newswire.
All rights reserved